首页 | 本学科首页   官方微博 | 高级检索  
检索        

复方18甲女用长效口服避孕药对恒河猴的远期安全性研究
引用本文:周化愚,罗其胜,罗国祥,徐维民,卢明义.复方18甲女用长效口服避孕药对恒河猴的远期安全性研究[J].生殖与避孕,1988(1).
作者姓名:周化愚  罗其胜  罗国祥  徐维民  卢明义
作者单位:中国医学科学院医学生物学研究所 昆明 (周化愚,罗其胜,罗国祥,徐维民),中国医学科学院医学生物学研究所 昆明(卢明义)
摘    要:选用40例成年健康雌性恒河猴(Macaca mulatta)为实验对象,随机将猴均分为两组。服药猴每月定日喂复方18甲1次,剂量按体重计算,约为妇女月用量的两倍。连续给药6年,停药观察4年。对照猴不给药,在相同条件下饲养观察10年。10年内先后进行了药物与肿瘤学、细胞遗传学和生殖内分泌学等方面的观察。结果表明:该药未能诱发猴的恶性肿瘤;没有造成猴子宫内膜超微结构的明显变化和损伤;不引起猴淋巴细胞染色体的畸变率和SCE 频率发生有统计学意义的改变;服药期间猴的排卵被抑制,停药一段时间后,排卵恢复,并能生育,说明恒河猴长期用该药是安全的。

关 键 词:复方18甲  长效口服避孕药  恒河猴  远期安全性

A STUDY ON THE CHRONIC TOXICITY OF THE FEMALE ORAL LONG-ACTING CONTRACEPTIVE(NORGESTREL COMPOSITA)IN RHESUS MONKEY(MACACA MULATA)
Zhou Hua-yu et al.A STUDY ON THE CHRONIC TOXICITY OF THE FEMALE ORAL LONG-ACTING CONTRACEPTIVE(NORGESTREL COMPOSITA)IN RHESUS MONKEY(MACACA MULATA)[J].Reproduction and Contraception,1988(1).
Authors:Zhou Hua-yu
Abstract:40 healthy female rhesus monkeys were selected to be the object for experimentation.Theywere devided into two groups randomly.To the monkeys of the testing group two timesthe dose of Norgestrel Composita for adult woman was administered monthly to each animalfor six years,with 4 additional years of observation after termination of medication.Thecytogenetics and reproductive endocrinology of this drug were observed.Malignanttumor,significant ultramicrostructural change or damage of endometrium,statisticallysignificant change of SCE frequency and teratogenic incidence of chromosomes oflymphocytes were not found in this experiment.Ovulation of the female monkeyshad been inhibited but recovered after termination of medication for a period of timeand the females were able to bear newborn.The results indicate that NorgestrelCompositais safe in use.
Keywords:Norgestrel composita  Rhesus monkey
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号